Your browser doesn't support javascript.
loading
Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes.
Bahne, Emilie; Sun, Emily W L; Young, Richard L; Hansen, Morten; Sonne, David P; Hansen, Jakob S; Rohde, Ulrich; Liou, Alice P; Jackson, Margaret L; de Fontgalland, Dayan; Rabbitt, Philippa; Hollington, Paul; Sposato, Luigi; Due, Steven; Wattchow, David A; Rehfeld, Jens F; Holst, Jens J; Keating, Damien J; Vilsbøll, Tina; Knop, Filip K.
Afiliación
  • Bahne E; Clinical Metabolic Physiology, Steno Diabetes Center Copenhagen, Gentofte Hospital, Hellerup, Denmark.
  • Sun EWL; Discipline of Human Physiology and Centre for Neuroscience, Flinders University of South Australia, Adelaide, Australia.
  • Young RL; Adelaide Medical School, University of Adelaide, Adelaide, Australia.
  • Hansen M; Nutrition and Metabolism, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia.
  • Sonne DP; Clinical Metabolic Physiology, Steno Diabetes Center Copenhagen, Gentofte Hospital, Hellerup, Denmark.
  • Hansen JS; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University Copenhagen, Copenhagen, Denmark.
  • Rohde U; Clinical Metabolic Physiology, Steno Diabetes Center Copenhagen, Gentofte Hospital, Hellerup, Denmark.
  • Liou AP; Department of Clinical Pharmacology, Frederiksberg and Bispebjerg Hospital, University of Copenhagen, Denmark.
  • Jackson ML; Clinical Metabolic Physiology, Steno Diabetes Center Copenhagen, Gentofte Hospital, Hellerup, Denmark.
  • de Fontgalland D; Clinical Metabolic Physiology, Steno Diabetes Center Copenhagen, Gentofte Hospital, Hellerup, Denmark.
  • Rabbitt P; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University Copenhagen, Copenhagen, Denmark.
  • Hollington P; Cardiovascular and Metabolic Diseases Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, USA.
  • Sposato L; Cardiovascular and Metabolic Diseases Research Unit, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, USA.
  • Due S; Discipline of Surgery, Flinders University, Adelaide, South Australia, Australia.
  • Wattchow DA; Discipline of Surgery, Flinders University, Adelaide, South Australia, Australia.
  • Rehfeld JF; Discipline of Surgery, Flinders University, Adelaide, South Australia, Australia.
  • Holst JJ; Discipline of Surgery, Flinders University, Adelaide, South Australia, Australia.
  • Keating DJ; Discipline of Surgery, Flinders University, Adelaide, South Australia, Australia.
  • Vilsbøll T; Discipline of Surgery, Flinders University, Adelaide, South Australia, Australia.
  • Knop FK; Department of Clinical Biochemistry, Rigshospitalet, University Copenhagen, Copenhagen, Denmark.
JCI Insight ; 3(23)2018 12 06.
Article en En | MEDLINE | ID: mdl-30518693
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Péptido 1 Similar al Glucagón / Metformina Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: JCI Insight Año: 2018 Tipo del documento: Article País de afiliación: Dinamarca
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Péptido 1 Similar al Glucagón / Metformina Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: JCI Insight Año: 2018 Tipo del documento: Article País de afiliación: Dinamarca